ALSO IN THIS MONTH'S ISSUE

BEYOND THE PRINTED PAGE

  • MAPS: Walking The Talk On Intellectual Property?
    4/29/2022

    Did MAPS, a leader in the psychedelic medicines space, just make good on its promise to share its intellectual property, as opposed to wielding it against competitors?

  • Where Patients Meet Policy: The EveryLife Foundation For Rare Diseases
    4/1/2022

    The year before he founded Ultragenyx, Emil Kakkis created the EveryLife Foundation for Rare Diseases, a nonprofit patient advocacy organization focused on the “equitable development of and access to lifesaving diagnoses, treatments, and cures.” We caught up with Annie Kennedy, chief of policy and advocacy at the EveryLife Foundation, to learn more about the issues and policies the foundation is prioritizing this year.

  • Ever Learn A Lesson The Hard Way?
    1/24/2022

    Bernard Coulie, M.D., Ph.D., president and CEO of Pliant Therapeutics, a company developing treatments for fibrotic diseases, shares a lesson learned the hard way involving an exit from a previous startup.

JULY 2022 DIGITAL EDITION

2022 CMO & CRO AWARDS EDITION

@LIFESCILEADER1